Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have symptoms of a neurological problem (such as weakness, speech difficulty, or other stroke-related symptoms) caused by an ischemic stroke (a stroke caused by a blocked blood vessel).
- People whose symptoms started no more than 4.5 hours before treatment begins — where "time of onset" is counted from the last moment the person was seen to be well and normal.
- People who are 18 years of age or older.
- People who have given signed consent to participate, either themselves or through a legally authorised representative.
Who may not be able to join:
- People who have any absolute reason (contraindication) against receiving clot-dissolving treatment, as listed in the Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2023 (confirm with trial site for the full list of these reasons).
- People who have a known allergy to TNK (tenecteplase) or alteplase, which are the clot-dissolving medications used in this type of treatment.
- People who have taken part in another clinical trial within the past 3 months.
- People who have other conditions that the trial team considers unsuitable for participation in this study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jialing Wu, MD,PhD, Tianjin Huanhu Hospital
Phone: 400-802-7885
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
mRS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.